Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Curr Diabetes Rev ; 6(5): 294-303, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20594163

RESUMEN

The global diabetes burden is predicted to rise to 380 million by 2025 and would present itself as a major health challenge. However, both Type 1 and Type 2 diabetes increase the risk of developing micro-vascular complications and macro-vascular complications which in turn will have a devastating impact on quality of life of the patients and challenge health services Worldwide. The micro-vascular complications that affect small blood vessels are the leading cause of blindness (diabetic retinopathy) in the people of the working-age, end-stage renal disease (diabetic nephropathy) the most common cause of kidney failure today, and foot amputation (diabetic neuropathy) in patients with Type 1 and Type 2 diabetes. It is accepted that hyperglycemia is a major causative factor for the development of these complications, there is also growing evidence for the role of inflammation. Here we discuss low-grade inflammation as a common retinal-renal-nerve pathogenic link in patients with Type 1 and Type 2 diabetes. This review summarizes evidence showing a link between circulating and locally produced inflammatory biomarkers, such as cell adhesion molecules (vascular adhesion cell molecule-1, VCAM-1; intracellular adhesion molecule-1, ICAM-1), pro-inflammatory cytokines (interleukin-6, IL-6; tumour necrosis factor-alpha, TNF-α; C-reactive protein, CRP) with the development and progression of diabetic micro-vascular complications.


Asunto(s)
Neuropatías Diabéticas/etiología , Inflamación/complicaciones , Riñón/inervación , Neuronas Retinianas/patología , Animales , Biomarcadores/análisis , Biomarcadores/sangre , Biomarcadores/metabolismo , Nefropatías Diabéticas/sangre , Nefropatías Diabéticas/etiología , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/patología , Neuropatías Diabéticas/sangre , Neuropatías Diabéticas/metabolismo , Neuropatías Diabéticas/patología , Retinopatía Diabética/sangre , Retinopatía Diabética/etiología , Retinopatía Diabética/metabolismo , Retinopatía Diabética/patología , Humanos , Inflamación/sangre , Inflamación/metabolismo , Inflamación/patología , Riñón/metabolismo , Riñón/patología , Modelos Biológicos , Nefritis/sangre , Nefritis/complicaciones , Nefritis/metabolismo , Nefritis/patología , Retina/inmunología , Retina/metabolismo , Retina/patología , Neuronas Retinianas/metabolismo , Retinitis/sangre , Retinitis/complicaciones , Retinitis/metabolismo , Retinitis/patología
2.
Curr Pharm Des ; 12(34): 4445-68, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17168753

RESUMEN

Nitric oxide (NO) is a small, highly reactive, diffusible free radical which has been implicated in many physiological and pathophysiological processes. It has either pro-apoptotic or anti-apoptotic effects on cells, depending upon a host of factors. This review outlines some of the regulatory molecules and organelles involved in the apoptotic pathways that can be influenced by the presence of NO, including p53, Bcl-2, caspases, mitochondria, and heat shock proteins. The effects of NO on the apoptosis of tumour cells are also examined.


Asunto(s)
Apoptosis , Neoplasias/metabolismo , Óxido Nítrico/metabolismo , Transducción de Señal , Animales , Caspasas/metabolismo , Proliferación Celular , Transformación Celular Neoplásica/metabolismo , Proteínas de Choque Térmico/metabolismo , Humanos , Metaloproteinasas de la Matriz/metabolismo , Mitocondrias/metabolismo , Neoplasias/irrigación sanguínea , Neoplasias/patología , Neovascularización Patológica/metabolismo , Óxido Nítrico Sintasa/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína p53 Supresora de Tumor/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA